BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 28823404)

  • 1. Development of a virtual spacer to support the decision for the placement of an implantable rectum spacer for prostate cancer radiotherapy: Comparison of dose, toxicity and cost-effectiveness.
    van Wijk Y; Vanneste BGL; Walsh S; van der Meer S; Ramaekers B; van Elmpt W; Pinkawa M; Lambin P
    Radiother Oncol; 2017 Oct; 125(1):107-112. PubMed ID: 28823404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Who will benefit most from hydrogel rectum spacer implantation in prostate cancer radiotherapy? A model-based approach for patient selection.
    Vanneste BG; Hoffmann AL; van Lin EN; Van De Voorde L; Pinkawa M; Lambin P
    Radiother Oncol; 2016 Oct; 121(1):118-123. PubMed ID: 27647458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an isotoxic decision support system integrating genetic markers of toxicity for the implantation of a rectum spacer.
    van Wijk Y; Vanneste BGL; Jochems A; Walsh S; Oberije CJ; Pinkawa M; Ramaekers BLT; Vega A; Lambin P
    Acta Oncol; 2018 Nov; 57(11):1499-1505. PubMed ID: 29952681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of a rectal spacer with prostate SABR-first UK experience.
    King RB; Osman SO; Fairmichael C; Irvine DM; Lyons CA; Ravi A; O'Sullivan JM; Hounsell AR; Mitchell DM; McGarry CK; Jain S
    Br J Radiol; 2018 Feb; 91(1083):20170672. PubMed ID: 29182384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensity modulated proton and photon therapy for early prostate cancer with or without transperineal injection of a polyethylen glycol spacer: a treatment planning comparison study.
    Weber DC; Zilli T; Vallee JP; Rouzaud M; Miralbell R; Cozzi L
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e311-8. PubMed ID: 22999271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multi-institutional clinical trial of rectal dose reduction via injected polyethylene-glycol hydrogel during intensity modulated radiation therapy for prostate cancer: analysis of dosimetric outcomes.
    Song DY; Herfarth KK; Uhl M; Eble MJ; Pinkawa M; van Triest B; Kalisvaart R; Weber DC; Miralbell R; Deweese TL; Ford EC
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):81-7. PubMed ID: 23414766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of a spacer gel to optimize three-dimensional conformal and intensity modulated radiotherapy for prostate cancer.
    Pinkawa M; Corral NE; Caffaro M; Piroth MD; Holy R; Djukic V; Otto G; Schoth F; Eble MJ
    Radiother Oncol; 2011 Sep; 100(3):436-41. PubMed ID: 21963289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Volumetric-modulated arc stereotactic body radiotherapy for prostate cancer: dosimetric impact of an increased near-maximum target dose and of a rectal spacer.
    Ruggieri R; Naccarato S; Stavrev P; Stavreva N; Fersino S; Giaj Levra N; Mazzola R; Mancosu P; Scorsetti M; Alongi F
    Br J Radiol; 2015 Oct; 88(1054):20140736. PubMed ID: 26235142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrogel Spacer Prospective Multicenter Randomized Controlled Pivotal Trial: Dosimetric and Clinical Effects of Perirectal Spacer Application in Men Undergoing Prostate Image Guided Intensity Modulated Radiation Therapy.
    Mariados N; Sylvester J; Shah D; Karsh L; Hudes R; Beyer D; Kurtzman S; Bogart J; Hsi RA; Kos M; Ellis R; Logsdon M; Zimberg S; Forsythe K; Zhang H; Soffen E; Francke P; Mantz C; Rossi P; DeWeese T; Hamstra DA; Bosch W; Gay H; Michalski J
    Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):971-977. PubMed ID: 26054865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ion therapy of prostate cancer: daily rectal dose reduction by application of spacer gel.
    Rucinski A; Brons S; Richter D; Habl G; Debus J; Bert C; Haberer T; Jäkel O
    Radiat Oncol; 2015 Feb; 10():56. PubMed ID: 25886457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of prostate-rectum separation on rectal dose from external beam radiotherapy.
    Susil RC; McNutt TR; DeWeese TL; Song D
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1251-8. PubMed ID: 19939577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrogel spacers in prostate radiotherapy: a promising approach to decrease rectal toxicity.
    Padmanabhan R; Pinkawa M; Song DY
    Future Oncol; 2017 Dec; 13(29):2697-2708. PubMed ID: 29168659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric and radiobiological consequences of computed tomography-guided adaptive strategies for intensity modulated radiation therapy of the prostate.
    Battista JJ; Johnson C; Turnbull D; Kempe J; Bzdusek K; Van Dyk J; Bauman G
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):874-80. PubMed ID: 23978708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IMRT boost dose planning on dominant intraprostatic lesions: gold marker-based three-dimensional fusion of CT with dynamic contrast-enhanced and 1H-spectroscopic MRI.
    van Lin EN; Fütterer JJ; Heijmink SW; van der Vight LP; Hoffmann AL; van Kollenburg P; Huisman HJ; Scheenen TW; Witjes JA; Leer JW; Barentsz JO; Visser AG
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):291-303. PubMed ID: 16618584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective evaluation of a hydrogel spacer for rectal separation in dose-escalated intensity-modulated radiotherapy for clinically localized prostate cancer.
    Eckert F; Alloussi S; Paulsen F; Bamberg M; Zips D; Spillner P; Gani C; Kramer U; Thorwarth D; Schilling D; Müller AC
    BMC Cancer; 2013 Jan; 13():27. PubMed ID: 23336502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helical tomotherapy vs. intensity-modulated proton therapy for whole pelvis irradiation in high-risk prostate cancer patients: dosimetric, normal tissue complication probability, and generalized equivalent uniform dose analysis.
    Widesott L; Pierelli A; Fiorino C; Lomax AJ; Amichetti M; Cozzarini C; Soukup M; Schneider R; Hug E; Di Muzio N; Calandrino R; Schwarz M
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1589-600. PubMed ID: 21167651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dosimetric study of polyethylene glycol hydrogel in 200 prostate cancer patients treated with high-dose rate brachytherapy±intensity modulated radiation therapy.
    Strom TJ; Wilder RB; Fernandez DC; Mellon EA; Saini AS; Hunt DC; Pow-Sang JM; Spiess PE; Sexton WJ; Poch MA; Biagioli MC
    Radiother Oncol; 2014 Apr; 111(1):126-31. PubMed ID: 24746567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel model to correlate hydrogel spacer placement, perirectal space creation, and rectum dosimetry in prostate stereotactic body radiotherapy.
    Hwang ME; Black PJ; Elliston CD; Wolthuis BA; Smith DR; Wu CC; Wenske S; Deutsch I
    Radiat Oncol; 2018 Oct; 13(1):192. PubMed ID: 30285812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SpaceOAR Hydrogel in Dose-escalated Prostate Cancer Radiotherapy: Rectal Dosimetry and Late Toxicity.
    Whalley D; Hruby G; Alfieri F; Kneebone A; Eade T
    Clin Oncol (R Coll Radiol); 2016 Oct; 28(10):e148-54. PubMed ID: 27298241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies for online organ motion correction for intensity-modulated radiotherapy of prostate cancer: prostate, rectum, and bladder dose effects.
    Rijkhorst EJ; Lakeman A; Nijkamp J; de Bois J; van Herk M; Lebesque JV; Sonke JJ
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1254-60. PubMed ID: 19857789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.